Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice
暂无分享,去创建一个
Yun-Ping Deng | Dan Goldowitz | S. Hersch | A. Reiner | F. Fusco | N. D. Del Mar | D. Goldowitz | Anton Reiner | Nobel Del Mar | Steven Hersch | Christopher A Meade | Francesca R Fusco | Yunping Deng | C. Meade
[1] Christopher A Ross,et al. Widespread expression of Huntington's disease gene (IT15) protein product , 1995, Neuron.
[2] A. Hackam,et al. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates , 1998, Nature Genetics.
[3] H. Wiśniewski,et al. Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. , 1973, Archives of neurology.
[4] D. Borchelt,et al. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. , 1999, Human molecular genetics.
[5] R. Tanzi,et al. Neuronal Intranuclear Inclusions in Polyglutamine Diseases Nuclear Weapons or Nuclear Fallout? , 1998, Neuron.
[6] S. Haber,et al. Mechanisms of striatal pattern formation: conservation of mammalian compartmentalization. , 1990, Brain research. Developmental brain research.
[7] A. Lavdas,et al. The Medial Ganglionic Eminence Gives Rise to a Population of Early Neurons in the Developing Cerebral Cortex , 1999, The Journal of Neuroscience.
[8] J. Penney,et al. Huntingtin localization in brains of normal and Huntington's disease patients , 1997, Annals of neurology.
[9] J. Penney,et al. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. , 1990, The New England journal of medicine.
[10] Joseph B. Martin,et al. Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease , 1987, Brain Research.
[11] Christopher A. Ross,et al. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease , 1991, Neuroscience Letters.
[12] Lisa Garrett,et al. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA , 1998, Nature Genetics.
[13] D. Tagle,et al. Recent advances in understanding the pathogenesis of Huntington's disease , 1999, Trends in Neurosciences.
[14] M. MacDonald,et al. Normal and Expanded Huntington’s Disease Gene Alleles Produce Distinguishable Proteins Due to Translation Across the CAG Repeat , 1995, Molecular medicine.
[15] M. Chesselet,et al. Decrease in Striatal Enkephalin mRNA in Mouse Models of Huntington’s Disease , 2000, Experimental Neurology.
[16] M. MacDonald,et al. Trinucleotide instability: a repeating theme in human inherited disorders. , 1996, Annual review of medicine.
[17] A. Reiner,et al. Relative Survival of Striatal Projection Neurons and Interneurons after Intrastriatal Injection of Quinolinic Acid in Rats , 1994, Experimental Neurology.
[18] D. Surmeier,et al. Cellular Localization of Huntingtin in Striatal and Cortical Neurons in Rats: Lack of Correlation with Neuronal Vulnerability in Huntington’s Disease , 1999, The Journal of Neuroscience.
[19] P. Brundin,et al. Recent Advances on the Pathogenesis of Huntington's Disease , 1999, Experimental Neurology.
[20] S. W. Davies,et al. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions? , 1998, The Lancet.
[21] Claire-Anne Gutekunst,et al. A YAC Mouse Model for Huntington’s Disease with Full-Length Mutant Huntingtin, Cytoplasmic Toxicity, and Selective Striatal Neurodegeneration , 1999, Neuron.
[22] D. Bessert,et al. The identification of a functional nuclear localization signal in the Huntington disease protein. , 1995, Brain research. Molecular brain research.
[23] Joseph B. Martin,et al. Somatostatin and neuropeptide Y concentrations in pathologically graded cases of huntington's disease , 1988, Annals of neurology.
[24] R. Durbin,et al. Structure and expression of the Huntington's disease gene: Evidence against simple inactivation due to an expanded CAG repeat , 1994, Somatic cell and molecular genetics.
[25] R A Crowther,et al. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Dom,et al. Neuropathology of Huntington's chorea , 1976, Neurology.
[27] H. Kita,et al. Parvalbumin-immunoreactive neurons in the rat neostriatum: a light and electron microscopic study , 1990, Brain Research.
[28] E. Wanker,et al. Huntington's Disease Intranuclear Inclusions Contain Truncated, Ubiquitinated Huntingtin Protein , 1999, Experimental Neurology.
[29] J. Mandel,et al. Pathological mechanisms in Huntington's disease and other polyglutamine expansion diseases. , 1998, Essays in biochemistry.
[30] R. S. Williams,et al. Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease , 1993, Neurology.
[31] Harry T Orr,et al. Mutation of the E6-AP Ubiquitin Ligase Reduces Nuclear Inclusion Frequency While Accelerating Polyglutamine-Induced Pathology in SCA1 Mice , 1999, Neuron.
[32] H. Johnston,et al. A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. , 1999, Human molecular genetics.
[33] Shihua Li,et al. Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. , 1998, Human molecular genetics.
[34] P. Emson,et al. Calbindin D28K as a marker for the degeneration of the striatonigral pathway in Huntington's disease , 1990, Brain Research.
[35] Intranuclear inclusions in subtypes of striatal neurons in Huntington's disease transgenic mice. , 1999, Neuroreport.
[36] M. Zasloff. tRNA transport from the nucleus in a eukaryotic cell: carrier-mediated translocation process. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[37] Michael R. Hayden,et al. The Influence of Huntingtin Protein Size on Nuclear Localization and Cellular Toxicity , 1998, The Journal of cell biology.
[38] D. Housman,et al. Evidence for a recruitment and sequestration mechanism in Huntington's disease. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[39] E. Hirsch,et al. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form , 1995, Nature Genetics.
[40] E. Richfield,et al. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients , 1995, Annals of neurology.
[41] G. Hoffman,et al. cFos immunoreactivity is enhanced with biotin amplification. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[42] G. Reynolds,et al. Brain GABA levels in asymptomatic Huntington's disease. , 1990, The New England journal of medicine.
[43] Claire-Anne Gutekunst,et al. Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology , 1999, The Journal of Neuroscience.
[44] R W Guillery,et al. Quantification without pontification: Choosing a method for counting objects in sectioned tissues , 1997, The Journal of comparative neurology.
[45] A. Reiner,et al. Relative Resistance of Striatal Neurons Containing Calbindin or Parvalbumin to Quinolinic Acid-Mediated Excitotoxicity Compared to Other Striatal Neuron Types , 1998, Experimental Neurology.
[46] S. W. Davies,et al. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[47] Stephen B. Dunnett,et al. Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease Mutation , 1999, The Journal of Neuroscience.
[48] M. MacDonald,et al. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. , 2000, Human molecular genetics.
[49] A. Reiner,et al. A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections , 1999, Journal of Neuroscience Methods.
[50] S. Anderson,et al. Mutations of the Homeobox Genes Dlx-1 and Dlx-2 Disrupt the Striatal Subventricular Zone and Differentiation of Late Born Striatal Neurons , 1997, Neuron.
[51] R. Albin,et al. Genetics and molecular biology of Huntington's disease , 1995, Trends in Neurosciences.
[52] E. Hirsch,et al. Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset , 1998, Neuroreport.
[53] Joseph B. Martin,et al. Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum , 1986, Neuroscience Letters.
[54] A. Morton,et al. Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation , 2000, Journal of neurocytology.
[55] M. MacDonald,et al. Heterogeneous Topographic and Cellular Distribution of Huntingtin Expression in the Normal Human Neostriatum , 1997, The Journal of Neuroscience.
[56] R. Roos,et al. Analysis of the subcellular localization of huntingtin with a set of rabbit polyclonal antibodies in cultured mammalian cells of neuronal origin: comparison with the distribution of huntingtin in Huntington's disease autopsy brain. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[57] T. Harris,et al. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. , 1989, Journal of immunological methods.
[58] S. Sisodia. Nuclear Inclusions in Glutamine Repeat Disorders Are They Pernicious, Coincidental, or Beneficial? , 1998, Cell.
[59] M. MacDonald,et al. Huntington's disease gene: Regional and cellular expression in brain of normal and affected individuals , 1995, Annals of neurology.
[60] K. Fischbeck,et al. Intranuclear Inclusions of Expanded Polyglutamine Protein in Spinocerebellar Ataxia Type 3 , 1997, Neuron.
[61] C. Wilson,et al. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[62] J T Finch,et al. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[63] C A Ross,et al. Intranuclear Neuronal Inclusions: A Common Pathogenic Mechanism for Glutamine-Repeat Neurodegenerative Diseases? , 1997, Neuron.
[64] S. W. Davies,et al. Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[65] J. B. Martin,et al. Selective sparing of a class of striatal neurons in Huntington's disease. , 1985, Science.
[66] R. Carraway,et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons , 1995, Neuron.
[67] P G Bhide,et al. Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain , 2001, Journal of neuropathology and experimental neurology.
[68] A Dürr,et al. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. , 1998, Human molecular genetics.
[69] A. Reiner,et al. Age-Dependent Differences in Survival of Striatal Somatostatin–NPY–NADPH–Diaphorase-Containing Interneurons versus Striatal Projection Neurons after Intrastriatal Injection of Quinolinic Acid in Rats , 1997, Experimental Neurology.
[70] G. V. Ommen,et al. Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain. , 1999, Journal of neuropathology and experimental neurology.
[71] S. Hersch,et al. Huntington aggregates may not predict neuronal death in Huntington's disease. , 1999, Annals of neurology.
[72] H. Robertson,et al. Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington’s disease mice , 2000, Neuroscience.
[73] S. Folstein,et al. Huntington's disease gene (IT15) is widely expressed in human and rat tissues , 1993, Neuron.
[74] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[75] H. Zoghbi,et al. Expanding Our Understanding of Polyglutamine Diseases through Mouse Models , 1999, Neuron.
[76] C A Ross,et al. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. , 2000, Human molecular genetics.
[77] W. Engel,et al. Immunocytochemical localization of ubiquitin in inclusion body myositis allows its light‐microscopic distinction from polymyositis , 1992, Neurology.
[78] M. Hayden,et al. Of molecular interactions, mice and mechanisms: new insights into Huntington's disease. , 1997, Current opinion in neurology.
[79] J. Penney,et al. Differential loss of striatal projection neurons in Huntington disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[80] W. J. Brammar,et al. Isolation and characterization of a novel gene with differential expression in benign and malignant human breast tumours. , 1992, Human molecular genetics.
[81] D. Rubinsztein,et al. A molecular investigation of true dominance in Huntington’s disease , 1999, Journal of medical genetics.
[82] Leyuan Shi,et al. Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes. , 1997, Science.
[83] R. Roos,et al. Characterization and localization of the Huntington disease gene product. , 1993, Human molecular genetics.
[84] D. Surmeier,et al. Evidence for the preferential localization of Glutamate Receptor-1 subunits of AMPA receptors to the dendritic spines of medium spiny neurons in rat striatum , 1998, Neuroscience.
[85] A. Reiner,et al. Calretinin is largely localized to a unique population of striatal interneurons in rats , 1996, Brain Research.
[86] S. Hersch,et al. Huntingtin aggregates may not predict neuronal death in Huntington's disease , 1999 .
[87] M. Beal,et al. The cortical lesion of Huntington's disease: Further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N‐methyl‐D‐aspartate lesions of rat cortex , 1992, Annals of neurology.
[88] S. W. Davies,et al. Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length , 1998, Neurobiology of Disease.
[89] P G Bhide,et al. Expression of Normal and Mutant Huntingtin in the Developing Brain , 1996, The Journal of Neuroscience.
[90] S. W. Davies,et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.
[91] A. Reiner,et al. Extensive co‐occurrence of substance P and dynorphin in striatal projection neurons: An evolutionarily conserved feature of basal ganglia organization , 1990, The Journal of comparative neurology.
[92] A. Morton,et al. Progressive depletion of complexin II in a transgenic mouse model of Huntington's disease , 2001, Journal of neurochemistry.
[93] J. Penney,et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease , 1999, Nature.
[94] E. McCusker,et al. Significant loss of pyramidal neurons in the angular gyrus of patients with Huntington's disease , 1997, Neuropathology and applied neurobiology.
[95] Harry T Orr,et al. Ataxin-1 Nuclear Localization and Aggregation Role in Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 1998, Cell.
[96] R H Myers,et al. Quantitative neuropathological changes in presymptomatic Huntington's disease , 2001, Annals of neurology.
[97] Virginia E. Papaioannou,et al. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue , 1995, Nature Genetics.
[98] S. W. Davies,et al. Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.
[99] Steven Finkbeiner,et al. Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.
[100] Charles J. Wilson,et al. Parvalbumin‐containing gabaergic interneurons in the rat neostriatum , 1990, The Journal of comparative neurology.
[101] A H Schapira,et al. Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse , 2000, Annals of neurology.
[102] M N Bobrow,et al. Catalyzed reporter deposition, a novel method of signal amplification. II. Application to membrane immunoassays. , 1991, Journal of immunological methods.
[103] M. Cudkowicz,et al. Degeneration of pyramidal projection neurons in Huntington's disease cortex , 1990, Annals of neurology.
[104] J. Mandel,et al. A cellular model that recapitulates major pathogenic steps of Huntington's disease. , 1998, Human molecular genetics.
[105] R. Albin,et al. Neurological abnormalities in a knock-in mouse model of Huntington's disease. , 2001, Human molecular genetics.
[106] M. MacDonald,et al. Amyloid Formation by Mutant Huntingtin: Threshold, Progressivity and Recruitment of Normal Polyglutamine Proteins , 1998, Somatic cell and molecular genetics.
[107] J. García-Verdugo,et al. Young neurons from medial ganglionic eminence disperse in adult and embryonic brain , 1999, Nature Neuroscience.
[108] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[109] J. Penney,et al. Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. , 1999, Journal of neuropathology and experimental neurology.
[110] A. Morton,et al. Selective Discrimination Learning Impairments in Mice Expressing the Human Huntington's Disease Mutation , 1999, The Journal of Neuroscience.
[111] D. Housman,et al. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[112] S B Dunnett,et al. Abnormal Synaptic Plasticity and Impaired Spatial Cognition in Mice Transgenic for Exon 1 of the Human Huntington's Disease Mutation , 2000, The Journal of Neuroscience.
[113] C. Gerfen,et al. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study , 1988, Brain Research.
[114] O. Quarrell. Glutamine repeats and neurodegenerative diseases: molecular aspects , 2001, Human Genetics.
[115] R. Crowther,et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .
[116] He Li,et al. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity , 2000, Nature Genetics.
[117] P. Silver,et al. Polyglutamine Expansions Proteolysis, Chaperones, and the Dangers of Promiscuity , 2000, Neuron.
[118] P. Greengard,et al. Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[119] J. Penney,et al. Preferential loss of striato‐external pallidal projection neurons in presymptomatic Huntington's disease , 1992, Annals of neurology.
[120] M. MacDonald,et al. Huntingtin Immunoreactivity in the Rat Neostriatum: Differential Accumulation in Projection and Interneurons , 1997, Experimental Neurology.
[121] J. Vonsattel,et al. Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease , 1988, Journal of neuropathology and experimental neurology.
[122] S. W. Davies,et al. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[123] J. Penney,et al. Homozygotes for Huntington's disease , 1987, Nature.
[124] C. Cepeda,et al. Changes in Cortical and Striatal Neurons Predict Behavioral and Electrophysiological Abnormalities in a Transgenic Murine Model of Huntington's Disease , 2001, The Journal of Neuroscience.
[125] L. Farrer,et al. Homozygote for Huntington disease. , 1989, American journal of human genetics.
[126] James F. Gusella,et al. Differential Expression of Normal and Mutant Huntington's Disease Gene Alleles , 1996, Neurobiology of Disease.
[127] A. Hackam,et al. The fatal attraction of polyglutamine‐containing proteins , 1998, Clinical genetics.
[128] R. Laskey,et al. Nuclear targeting sequences--a consensus? , 1991, Trends in biochemical sciences.
[129] H. Green,et al. Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[130] Yves Agid,et al. Differential distribution of the normal and mutated forms of huntingtin in the human brain , 1997, Annals of neurology.
[131] J. Mandel,et al. Pathological mechanisms in Huntington's disease and other polyglutamine expansion diseases , 1998 .
[132] J. Penney,et al. Striatal and nigral neuron subpopulations in rigid Huntington's disease: Implications for the functional anatomy of chorea and rigidity‐akinesia , 1990, Annals of neurology.
[133] A. Joyner,et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. , 1995, Science.
[134] Roger D. Kornberg,et al. Synthetic peptides as nuclear localization signals , 1986, Nature.
[135] Mark Turmaine,et al. Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.
[136] Michael A. Mancini,et al. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 , 1998, Nature Genetics.
[137] S. Floresco,et al. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes , 1995, Cell.
[138] J. Penney,et al. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis , 1995, Neuroscience.
[139] S. Hersch,et al. Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[140] M. MacDonald,et al. The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin. , 2001, Human molecular genetics.
[141] D. Newmeyer,et al. Assembly in vitro of nuclei active in nuclear protein transport: ATP is required for nucleoplasmin accumulation. , 1986, The EMBO journal.
[142] G. Bates. Expanded glutamines and neurodegeneration--a gain of insight. , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.
[143] G. Sancesario,et al. Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats , 1996, Brain Research.